| abstract |
The present disclosure provides methods and kits suitable for administering, eg, to a human subject in need thereof, a composition comprising an antibody that binds to human Siglec-8. In some embodiments, the corticosteroid is administered to the individual at least 6 hours, at least 12 hours, or 12-24 hours prior to the first dose of the composition comprising the anti-Siglec-8 antibody. |